title

Dealcast: The M&A Podcast

Dealreporter Europe

1
Followers
0
Plays
Dealcast: The M&A Podcast
Dealcast: The M&A Podcast

Dealcast: The M&A Podcast

Dealreporter Europe

1
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Podcast from the Dealreporter and Mergermarket European editorial teams looking at the latest developments in M&A, ECM and activism.

Latest Episodes

Dealcast: Allergan reaction

The European Commission (EC) is reviewing AbbVie’s [NYSE:ABBV] proposed acquisition of Botox producer Allergan [NYSE:AGN]. The merging parties have already pledged to divest such products as brazikumab, a drug under development for ulcerative colitis and Crohn’s disease, and Zenpep (pancrelipase), which treats a pancreatic disorder, but the EC may want more changes if it is to approve the deal. Dealreporter’s Pablo Mayo Cerqueiro and Mergermarket’s Mintoi Chessa-Florea joined us to discuss how the EC’s review is likely to go.

13 MINAUG 9
Comments
Dealcast: Allergan reaction

Dealcast: KKR’s play for Axel Springer

German media conglomerate Axel Springer [ETR:SPR] has caught the eye of KKR [NYSE:KKR]. With Axel Springer’s founding family supporting its bid, KKR has an easier route towards taking the target off the market. Activistmonitor editor William Mace and Mergermarket’s resident DACH expert Emma-Victoria Farr joined us to discuss what the deal could mean for Axel Springer’s future.

10 MINJUN 20
Comments
Dealcast: KKR’s play for Axel Springer

Dealreporter Asia: AGL Energy's offer for Vocus, Healius' investing in Japan and Kuyushu Railway Co's AGM

This 15-minute podcast discusses Asian deals and events of interest to hedge funds and other professional investors.

15 MINJUN 14
Comments
Dealreporter Asia: AGL Energy's offer for Vocus, Healius' investing in Japan and Kuyushu Railway Co's AGM

Dealcast Asia: Melco buys Crown stake, Qunar's surprise ruling

In this weekly edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Anette Jönsson discuss key developments on several Asian situations, including comments by Malaysia’s prime minister indicating Australian rare earth producer Lynas [ASX:LYC] will be allowed to continue operating in the Southeast Asian country; and the potential implications of casino tycoon James Packer selling part of his stake in Crown Resorts [ASX:CWN] to Melco Resorts & Entertainment [NASDAQ:MLCO] less than two months after his talks with Wynn Resorts [NASDAQ:WYNN] were terminated following a leak. At the end of the podcast we reveal an unexpected judicial setback for the dissenting shareholders of Qunar’s take-private that could have implications for ongoing and future Section 238 fair value processes in Cayman.

18 MINMAY 31
Comments
Dealcast Asia: Melco buys Crown stake, Qunar's surprise ruling

Dealcast: Tech listings go awry

Wobbly tech-sector IPOs, including those of Uber [NYSE:UBER] and Finablr [LON:FIN], have dampened the mood for ECM. Dealreporter ECM editor Gustav Sandstrom joined us to discuss how these high-profile fumbles could affect similar listings ahead this year.

9 MINMAY 29
Comments
Dealcast: Tech listings go awry

Dealcast Asia: SAMR leadership change, the latest on Lynas and upcoming deals

In this inaugural edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Ed Vinales discuss the appointment of a new head of China’s State Administration for Market Regulation (SAMR), and how the US-China trade dispute is impacting Wesfarmer’s hostile bid for rare-earth miner Lynas. Other situations covered include the hairy privatisation of Hong Kong’s Harbin Electric, and the ongoing sale processes surrounding Hitachi Chemical, and NXC Corp, which owns 47.68% of South Korea’s largest gaming company Nexon. The journalists end the podcast discussing why Australian development and construction business Lendlease could become a takeover target.

12 MINMAY 24
Comments
Dealcast Asia: SAMR leadership change, the latest on Lynas and upcoming deals

Dealcast: The case for European telecoms M&A

With European telecoms attracting takeover attention, Dealreporter editor Heba Abdelrahman and Mergermarket journalist Amy-Jo Crowley joined us to talk about the case for telecoms M&A, the obstacles standing in the way of deals in the space, and the likelihood of a deal for KPN [AMS:KPN].

10 MINMAY 10
Comments
Dealcast: The case for European telecoms M&A

Deutsche Bank and Commerzbank consider merger

Deutsche Bank and Commerzbank are exploring a merger. Dealreporter journalists Gustav Sandstrom and Pablo Mayo Cerqueiro joined us to discuss the likelihood of a deal, its justifications and drawbacks, and how it might be structured.

9 MINAPR 16
Comments
Deutsche Bank and Commerzbank consider merger

Shareholder activism and private equity

Activist investors are adapting their strategy to the top of the business cycle. Activistmonitor assistant editor William Mace and William Cain, who writes Dealreporter's Flash feature, joined us this week to speak about the intersection of private equity and shareholder activism.

13 MINAPR 4
Comments
Shareholder activism and private equity

Lundbeck ready to make acquisitions

Danish pharmaceutical company Lundbeck [CPH: LUN] is poised for a run of M&A to replenish its drug pipeline. We caught up with our Nordics reporter, Karoliina Liimatainen, who spoke recently with the company's chief executive, Deborah Dunsire, and has more on the company's plans for growth.

7 MINFEB 28
Comments
Lundbeck ready to make acquisitions

Latest Episodes

Dealcast: Allergan reaction

The European Commission (EC) is reviewing AbbVie’s [NYSE:ABBV] proposed acquisition of Botox producer Allergan [NYSE:AGN]. The merging parties have already pledged to divest such products as brazikumab, a drug under development for ulcerative colitis and Crohn’s disease, and Zenpep (pancrelipase), which treats a pancreatic disorder, but the EC may want more changes if it is to approve the deal. Dealreporter’s Pablo Mayo Cerqueiro and Mergermarket’s Mintoi Chessa-Florea joined us to discuss how the EC’s review is likely to go.

13 MINAUG 9
Comments
Dealcast: Allergan reaction

Dealcast: KKR’s play for Axel Springer

German media conglomerate Axel Springer [ETR:SPR] has caught the eye of KKR [NYSE:KKR]. With Axel Springer’s founding family supporting its bid, KKR has an easier route towards taking the target off the market. Activistmonitor editor William Mace and Mergermarket’s resident DACH expert Emma-Victoria Farr joined us to discuss what the deal could mean for Axel Springer’s future.

10 MINJUN 20
Comments
Dealcast: KKR’s play for Axel Springer

Dealreporter Asia: AGL Energy's offer for Vocus, Healius' investing in Japan and Kuyushu Railway Co's AGM

This 15-minute podcast discusses Asian deals and events of interest to hedge funds and other professional investors.

15 MINJUN 14
Comments
Dealreporter Asia: AGL Energy's offer for Vocus, Healius' investing in Japan and Kuyushu Railway Co's AGM

Dealcast Asia: Melco buys Crown stake, Qunar's surprise ruling

In this weekly edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Anette Jönsson discuss key developments on several Asian situations, including comments by Malaysia’s prime minister indicating Australian rare earth producer Lynas [ASX:LYC] will be allowed to continue operating in the Southeast Asian country; and the potential implications of casino tycoon James Packer selling part of his stake in Crown Resorts [ASX:CWN] to Melco Resorts & Entertainment [NASDAQ:MLCO] less than two months after his talks with Wynn Resorts [NASDAQ:WYNN] were terminated following a leak. At the end of the podcast we reveal an unexpected judicial setback for the dissenting shareholders of Qunar’s take-private that could have implications for ongoing and future Section 238 fair value processes in Cayman.

18 MINMAY 31
Comments
Dealcast Asia: Melco buys Crown stake, Qunar's surprise ruling

Dealcast: Tech listings go awry

Wobbly tech-sector IPOs, including those of Uber [NYSE:UBER] and Finablr [LON:FIN], have dampened the mood for ECM. Dealreporter ECM editor Gustav Sandstrom joined us to discuss how these high-profile fumbles could affect similar listings ahead this year.

9 MINMAY 29
Comments
Dealcast: Tech listings go awry

Dealcast Asia: SAMR leadership change, the latest on Lynas and upcoming deals

In this inaugural edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Ed Vinales discuss the appointment of a new head of China’s State Administration for Market Regulation (SAMR), and how the US-China trade dispute is impacting Wesfarmer’s hostile bid for rare-earth miner Lynas. Other situations covered include the hairy privatisation of Hong Kong’s Harbin Electric, and the ongoing sale processes surrounding Hitachi Chemical, and NXC Corp, which owns 47.68% of South Korea’s largest gaming company Nexon. The journalists end the podcast discussing why Australian development and construction business Lendlease could become a takeover target.

12 MINMAY 24
Comments
Dealcast Asia: SAMR leadership change, the latest on Lynas and upcoming deals

Dealcast: The case for European telecoms M&A

With European telecoms attracting takeover attention, Dealreporter editor Heba Abdelrahman and Mergermarket journalist Amy-Jo Crowley joined us to talk about the case for telecoms M&A, the obstacles standing in the way of deals in the space, and the likelihood of a deal for KPN [AMS:KPN].

10 MINMAY 10
Comments
Dealcast: The case for European telecoms M&A

Deutsche Bank and Commerzbank consider merger

Deutsche Bank and Commerzbank are exploring a merger. Dealreporter journalists Gustav Sandstrom and Pablo Mayo Cerqueiro joined us to discuss the likelihood of a deal, its justifications and drawbacks, and how it might be structured.

9 MINAPR 16
Comments
Deutsche Bank and Commerzbank consider merger

Shareholder activism and private equity

Activist investors are adapting their strategy to the top of the business cycle. Activistmonitor assistant editor William Mace and William Cain, who writes Dealreporter's Flash feature, joined us this week to speak about the intersection of private equity and shareholder activism.

13 MINAPR 4
Comments
Shareholder activism and private equity

Lundbeck ready to make acquisitions

Danish pharmaceutical company Lundbeck [CPH: LUN] is poised for a run of M&A to replenish its drug pipeline. We caught up with our Nordics reporter, Karoliina Liimatainen, who spoke recently with the company's chief executive, Deborah Dunsire, and has more on the company's plans for growth.

7 MINFEB 28
Comments
Lundbeck ready to make acquisitions